Linear growth (cm/week) · promoting short‐term growth of preterm infants
1 finding from 1 review
Growth: head circumference (cm/week) · promoting short‐term growth of preterm infants
1 finding from 1 review
Cerebral palsy · promoting short‐term growth of preterm infants
1 finding from 1 review
Developmental delay at ≥ 18 months · promoting short‐term growth of preterm infants
1 finding from 1 review
Death during study period · promoting short‐term growth of preterm infants
1 finding from 1 review
Miscarriage · couples undergoing embryo transfer
High showed no clear difference in miscarriage rate compared with low or no hyaluronic acid (low certainty).
1 finding from 1 review
Multiple pregnancy rate · couples undergoing embryo transfer
High probably leads to higher multiple pregnancy rate compared with low or no hyaluronic acid (moderate certainty).
1 finding from 1 review
Adverse event rate · couples undergoing embryo transfer
High showed no clear difference in adverse event rate compared with low or no hyaluronic acid (low certainty).
1 finding from 1 review
Death (any cause; sudden death) · people with CKD
High showed no clear difference in death (any cause; sudden death) compared with with low‐dose potassium binder (low certainty).
1 finding from 1 review
Cardiovascular mortality · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Arrhythmias · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serum potassium · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Constipation · people with CKD
High showed no clear difference in constipation compared with with low‐dose potassium binder (low certainty).
1 finding from 1 review
All‐cause mortality: range 1 mo to 1 y · adults admitted to the ICU
It is very uncertain whether higher changes all‐cause mortality: range 1 mo to 1 y compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more serious adverse events according to International Conference on Harmonisation Good Clinical Practice (ICH‐GCP) · adults admitted to the ICU
It is very uncertain whether higher changes proportion of participants with ≥ 1 serious adverse events according… compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Quality of life (any measure): range 180 d to 1 y · adults admitted to the ICU
1 finding from 1 review
Lung injury diagnosed after randomisation (composite outcome): range 4 d to 23 d · adults admitted to the ICU
It is very uncertain whether higher changes lung injury diagnosed after randomisation (composite outcome): range… compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Myocardial infarction · adults admitted to the ICU
It is very uncertain whether higher changes myocardial infarction diagnosed after randomisation: range ≤ 90 d compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
Stroke · adults admitted to the ICU
It is very uncertain whether higher changes stroke diagnosed after randomisation: range 1 mo to 3 mo compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review